Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
70% 0% |
 |
Eli Lilly and CompanyLLY |
81% 0% |
 |
PfizerPFE |
49% 0% |
 |
AbbVieABBV |
77% 1.3% |
 |
TherapeuticsMDTXMD |
33% 0% |
What Do Astrazeneca Employees Think About the Company?
79% of Astrazeneca (AZN) employees currently report a positive business outlook, based on anonymous employee surveys aggregated by AltIndex. This is a strong reading, which suggests employees are confident in the direction of the company.
The score is roughly flat (+0.0%) over the past three months.
At 79% positive, Astrazeneca’s employee business outlook trails industry peers like Johnson & Johnson (70%) and Eli Lilly and Company (81%).
Why Employee Sentiment Matters for AZN Stock
Employee business outlook can be a leading indicator: the people inside the business see operational changes, leadership decisions, and market shifts before they reach an earnings report. AltIndex feeds Astrazeneca’s outlook score into the AZN AI Score as one of 25+ alternative data signals, weighed alongside hiring, web traffic, and fundamentals.
For other employment signals, see Astrazeneca’s job postings, LinkedIn headcount, and overall employee rating.
Month over Month
| Jul 2026 | 79% | |
| Jun 2026 | 79% | |
| May 2026 | 79% | |
| Apr 2026 | 79% | |
| Mar 2026 | 78% | |
| Feb 2026 | 78% |
Astrazeneca Employee Business Outlook: Frequently Asked Questions
79% of Astrazeneca employees report a positive business outlook. This is based on anonymous employee surveys aggregated by AltIndex and updated regularly.
A 79% reading is strong — a clear majority of Astrazeneca employees are positive about where the business is headed.
No single signal predicts a stock on its own, but employee business outlook can be a leading indicator: employees see operational changes, morale shifts, and strategic pivots before they appear in quarterly earnings. AltIndex combines it with 25+ other signals in the AZN AI Score rather than reading any one signal in isolation.
Astrazeneca overperforms a majority of its industry peers when it comes to Business Outlook, ranking in the 79th percentile.
There has been no meaningful change in the business outlook amongst employees at Astrazeneca.
Sign up and get more insights on the business outlook at Astrazeneca.
See Astrazeneca’s complete business outlook history
Sign up to unlock 1-year and all-time charts for AZN — plus 25+ alternative data signals, AI Scores, and real-time alerts.
Sign up
